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Objectives: Travel-associated infections are challenging to diagnose because of the broad spectrum of 
potential aetiologies. As a proof-of-principle study, we used MNGS to identify viral pathogens in clinical 
samples from returning travellers in a single center to explore its suitability as a diagnostic tool. 
Methods: Plasma samples from 40 returning travellers presenting with a fever of ≥38 °C were sequenced 
using MNGS on the Illumina MiSeq platform and compared with standard-of-care diagnostic assays. 
Results: In total, 11/40 patients were diagnosed with a viral infection. Standard of care diagnostics re- 
vealed 5 viral infections using plasma samples; dengue virus 1 ( n = 2), hepatitis E ( n = 1), Ebola virus 
( n = 1) and hepatitis A ( n = 1), all of which were detected by MNGS. Three additional patients with 
Chikungunya virus ( n = 2) and mumps virus were diagnosed by MNGS only. Respiratory infections de- 
tected by nasal/throat swabs only were not detected by MNGS of plasma. One patient had infection with 
malaria and mumps virus during the same admission. 
Conclusions: MNGS analysis of plasma samples improves the sensitivity of diagnosis of viral infections 
and has potential as an all-in-one diagnostic test. It can be used to identify infections that have not been 
considered by the treating physician, co-infections and new or emerging pathogens. 
Summary: Next generation sequencing (NGS) has potential as an all-in-one diagnostic test. In this study 
we used NGS to diagnose returning travellers with acute febrile illness in the UK, highlighting cases 
where the diagnosis was missed using standard methods. 
© 2019 Published by Elsevier Ltd on behalf of The British Infection Association. 
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The ease of international travel has increased the potential for
ransmission of a wide range of viruses, including those of epi-
emic potential. Identifying these pathogens is crucial for treat-
ent and for the prevention of further transmission. Traditional
iagnostic tests require a priori knowledge of potential pathogenic
gents and it is increasingly challenging for infectious disease
hysicians to select relevant diagnostic tests for pathogens im-
orted from a wide number of locations across the globe. 1 Such∗ Corresponding authors at: MRC-University of Glasgow Centre for Virus Research, 
ir Michael Stoker Building, Room 302, 464 Bearsden Road, Glasgow G61 1QH, UK. 
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infections in febrile returning travellers, Journal of Infection, https://doests are often batched and sent to a reference laboratory, often
esulting in delayed diagnosis. Even specialized tests may fail to
dentify a rapidly evolving pathogen, due to the presence of varia-
ions at PCR primer binding sites. Furthermore, new and emerging
athogens cannot be identiﬁed using standard assays. In contrast,
ew or emerging infections and those not considered by a treat-
ng physician may readily be identiﬁed with MNGS. 2–6 Whole vi-
al genome sequences generated using MinION or Illumina-based
echnology additionally be used for resistance screening and ﬁne-
cale phyloepidemiological analyses to inform public health control
trategies. 7,8 In this study, we aimed to evaluate the potential for
NGs as an all-in-one diagnostic tool in febrile patients with a re-
ent history of overseas travel. 
The value of MNGS as a tool to identify pathogens not iden-
iﬁed by traditional methods has been described in case reports. 
tagenomic next-generation sequencing aids the diagnosis of viral 
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Pof patients infected with a number of pathogens. One notable
example involved the use of MNGS to diagnose a 14-year old
boy with neuroleptospirosis, resulting in a change of management
to incorporate appropriate antibacterial therapy. 9 It has also been
used in outbreaks of viral haemorrhagic fever (VHF) where stan-
dard diagnostic assays did not reveal a diagnosis. 5,10 A novel strain
of Ebola virus, Bundibugyo virus, not readily identiﬁed using stan-
dard assays was identiﬁed following metagenomic 454 pyrose-
quencing of patient samples in 2008 during an outbreak of VHF
in Western Uganda. 5 454 pyrosequencing and subsequently Illu-
mina sequencing were used in another outbreak of viral haemor-
rhagic fever in the Democratic Republic of the Congo and revealed
a novel rhabdovirus – Bas Congo virus – as the aetiological agent. 10 
Causes of VHF had previously included members of the Filovirus
and Arenavirus families but not the Rhabdovirus family and there-
fore pathogen-speciﬁc diagnostic assays would have been unhelp-
ful. Without the use of MNGS, it is unlikely that this pathogen
would have been identiﬁed. 
A number of NGS platforms have been used to diagnose vi-
ral pathogens, based on different technologies. 11 These are divided
into short and long-read methods. At present, short read methods
are higher-throughput and cheaper than long-read methods. Short
read methods divide into sequencing by ligation and sequencing by
synthesis. 454 pyrosequencing (in which the release of a pyrophos-
phate is incorporated in a sequencing by synthesis reaction that re-
sults in the release of light) was the ﬁrst available short read NGS
platform but is limited by a high error rate (largely due to polynu-
cleotide repeats). Illumina sequencing is also a short-read sequenc-
ing by synthesis method and is based on the high-throughput de-
tection of ﬂuorescent markers as they are incorporated into an ex-
panding chain. It is cheaper and has a higher level of accuracy al-
lowing accurate sequencing of genomes from new pathogens and
for ﬁne-scale phyloepidemiology. It is limited by sequence read
lengths of around 500 base pairs, requiring advanced bioinformatic
software to reconstruct viral genomes. Longer sequence reads may
be acquired on other platforms such as the PacBio, the Oxford
nanopore and the Ion Torrent platforms that are based on semi-
conductor technology (due to a change in ionic charge when a base
is added to the expanding chain). These technologies are limited
however by a decreased accuracy when compared with Illumina-
based methods. A particularly exciting advance has been the de-
velopment of the MinIon platform which is portable, the size of a
mobile telephone and can be used in the ﬁeld without an external
internet or power source. 12 The MinIon platform has been used re-
cently to track the Zika virus outbreak in South America and Ebola
virus disease in the Democratic Republic of Congo. 12,13 It is lim-
ited in accuracy however and in the need for high concentrations
of input DNA necessitating prior ampliﬁcation of genomic material
by PCR but has potential for further development as a diagnostic
tool if high error rates can be addressed. 
Methods 
Patient consent and sample collection 
The retrospective use of samples from patients admitted with
a febrile illness following overseas travel between 2013 and 2016
was granted by the NHSGGC Bio-repository and Pathology Tissue
Resource committee (16/WS/0207NHS). Samples were anonymized
and patients who had not had an HIV test during admission were
excluded (to avoid the possibility of diagnosing a new HIV in-
fection using MNGS). Inclusion criteria were a fever greater than
38 °C, age ≥18 years, a preceding negative HIV test and over-
seas travel within 12 weeks of presentation to hospital. 44 sam-
ples from 40 patients were available for MNGS analysis. Diagnoses
were made by two blinded investigators (an infectious diseasesPlease cite this article as: H. Jerome, C. Taylor and V.B. Sreenu et al., Me
infections in febrile returning travellers, Journal of Infection, https://doonsultant physician and a senior laboratory scientist with exper-
ise in NGS data analysis) prior to comparison with clinical data. 
xtraction of DNA and RNA 
RNA and DNA were extracted from 200 μl of serum or plasma
amples using the automated NucliSens EasyMAG platform at the
est of Scotland Specialist Virology Centre, Glasgow Royal Inﬁr-
ary. Nucleic acid was eluted in 110 μl nuclease-free water and
tored at −80 °C until further processing. 
ouble stranded cDNA synthesis 
RNA was reverse transcribed into cDNA using Superscript III re-
erse transcriptase (Invitrogen) according to manufacturer’s recom-
endations. The total reaction volume from single-stranded cDNA
ynthesis (20 μl) was used to create double stranded cDNA with a
ew England Biolabs Second Strand cDNA synthesis kit according
o manufacturer’s recommendations in a ﬁnal volume of 80 μl. 
ibrary preparation and MiSeq sequencing 
For library preparation either the Kapa Library Preparation Kit
KK8232 Kapa Biosystems) or the Nextera XT Kit (Illumina FC-131-
024) was used in combination with the NEBNext® Multiplex Oli-
os for Illumina® (Index Primers Set 1 and 2, E7335 and E7500)
r the Nextera® XT Index Kit (FC-131-2001). To estimate the mo-
arity of DNA libraries after indexing PCR, DNA concentration was
easured using the High Sensitivity double-stranded DNA Qubit
ssay (Invitrogen), and the quality of the DNA was assessed us-
ng automated gel electrophoresis using a 2200 TapeStation Instru-
ent (Agilent Technologies). For DNA puriﬁcation between the li-
rary preparation steps, Agencourt® AMPure® XP magnetic beads
Beckman Coulter) and Solid Phase Reversible Immobilization so-
ution (SPRI, 20% PEG, 2.5 M NaCl) were used, respectively. Up to
0 DNA libraries were pooled together for 150 or 250 paired end
equencing using v2 or v3 cartridges (Illumina) on the MiSeq or
extSeq platform according to manufacturer’s recommendations. 
ioinformatic analysis 
Sequences of low quality and complexity and Illumina adaptor
equences were removed from raw fastq ﬁles using Trim_galore
Babraham Bioinformatics) and Prinseq. 14 Raw reads were used to
arry out a blastx search using diamond (version 0.8.20) software.
ubsequently, de novo assembly and mapping approaches were ap-
lied using SPAdes-3.8.0, 15 dipSPAdes 16 and Tanoti (version 1.3,
ttps://github.com/vbsreenu/Tanoti ). Contigs were identiﬁed using
LASTn and BLASTx (blastall version 2.2.26) against ncbi nr and
t databases and diamond databases. 17 The output was visualized
sing Krona plots and BLAST tables. 18 Additionally, a rapid hash-
ased exploration tool was created and evaluated (Anwesh). This
oftware applies BLAT to screen MNGS datasets with customized
urated databases of nucleotide sequences. Two databases were
reated for this purpose, derived from NCBI ( ftp://ftp.ncbi.nlm.nih.
ov/genomes/Viruses/ ) and the ‘Approved List of biological agents’
ublished by the UK Health and Safety Executive (HSE). When a
atch to a sequence was detected during screening with Anwesh
r by de novo assembly, this was used for mapping using Tanoti.
s MNGS is subject to low-level cross-contamination, we used a
hreshold of a minimum of coverage of 10% of the viral genome
or diagnosis and repeated testing from a run where a sample was
ositive with a higher number of mapped reads (Supplementary
ig. 1). This threshold was chosen as it approximates the size of
CR product used in routine diagnostic assays. tagenomic next-generation sequencing aids the diagnosis of viral 
i.org/10.1016/j.jinf.2019.08.003 
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Fig. 1. Viral and parasitic diagnoses using standard of care and MNGS testing. (a) Viral and parasitic diagnoses from plasma samples derived from returning travellers using 
standard of care diagnostics (white circle) and blinded retrospective MNGS analysis (gray circle). (b) Genome coverage, depth, number and distribution of mapped sequence 
reads. 
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m  onﬁrmatory testing 
Conﬁrmatory tests were carried out by PCR or serology in the
est of Scotland Specialist Virology Centre (WoSSVC), Glasgow
oyal Inﬁrmary or sent to the Rare and Imported Pathogens Labo-
atory (RIPL, Public Health England Porton Down). 
esults 
Plasma samples from 40 febrile returning travellers and 1
febrile control patient were analyzed using MNGS ( Fig. 1 ). Rel-
vant travel histories and clinical and standard of care labora-
ory diagnosis are listed in Supplementary Table 1. MNGS anal-
sis resulted in the detection of 8 viral genomes: Dengue virus
 (DENV1; n = 2; P17 and P35), Chikungunya virus (CHIKV; n = 2;
18 and P40), hepatitis E virus (HEV; n = 1; P11), hepatitis A virusPlease cite this article as: H. Jerome, C. Taylor and V.B. Sreenu et al., Me
infections in febrile returning travellers, Journal of Infection, https://doHAV; n = 1; P22), mumps virus ( n = 1; P34) and Ebola virus (EBOV;
 = 1; P41) ( Fig. 1 (a)). A range of depth and coverage of viral read
esults were identiﬁed (likely reﬂecting a variety of viral loads)
 Fig. 1 (b)). Three patients who were infected with respiratory
iruses based on viral throat swab testing – P12 (inﬂuenza A virus),
13 (inﬂuenza B virus), and P30 (rhinovirus) could not be fully
valuated by MNGS because respiratory samples were not available
or analysis. Additionally, human pegivirus (HPgV) was detected in
 patients (patients P4, P10 and P30). This is not currently consid-
red to be a human pathogen. These were all genotype 2 and one
train was highly divergent, nearly meeting the criteria for a new
enotype based on current ICTV recommendations (Supplementary
ig. 2). While the focus of this project was the detection of viral in-
ections, we also detected Plasmodium falciparum and Plasmodium
alariae genomic material in patients P2, P3, P21 and P29. Threetagenomic next-generation sequencing aids the diagnosis of viral 
i.org/10.1016/j.jinf.2019.08.003 
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Fig. 2. Phylogenetic analysis of whole viral open reading frames detected using NGS. 
Maximum likelihood phylogenetic analysis of patient samples and all available full genome reference sequences (NCBI) was carried out using RA ×ML and 10 0 0 bootstrap 
replicates. 
 
 
 
 
 
b
f  
S
 
f  patients (P24, P34 and P39) were found to have malaria on blood
ﬁlm sampling but not NGS (in each case the date of viral sampling
for NGS occurred subsequent to blood ﬁlm positive results). One of
these patients (P34) had been diagnosed previously with P. falci-
parum malaria on blood ﬁlm and had sampling for other pathogensPlease cite this article as: H. Jerome, C. Taylor and V.B. Sreenu et al., Me
infections in febrile returning travellers, Journal of Infection, https://doecause of ongoing fever and lymphadenopathy despite therapy –
ragments of mumps virus genome were detected in this sample.
ubsequent PCR testing by the diagnostic laboratory was negative. 
Maximum likelihood phylogenetic analysis of DENV and CHIKV
ull genomes ( Fig. 2 ) revealed that the CHIKV viral genome fromtagenomic next-generation sequencing aids the diagnosis of viral 
i.org/10.1016/j.jinf.2019.08.003 
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 18 clustered within the Asian strain of CHIKV and was most
losely associated with other CHIKV strains from Indonesia in
eeping with the travel history of the patient. Phylogenetic anal-
sis of the DENV strains revealed that P35, a returning traveller
rom Thailand had a strain clustering with genotype 1 strain from
hina and Thailand while P17, a returning traveller from the Mal-
ives had a strain most closely related to strains from Sri Lanka
this is the ﬁrst published DENV whole genome sequence from the
aldives). Whole genomes detected in the study have been sub-
itted to GenBank (accession numbers to follow). 
iscussion 
MNGS has the potential to improve the diagnostic yield of vi-
al, bacterial and parasitic infectious diseases. 2 , 19–28 Importantly,
t does not require the requesting physician to consider all diag-
ostic possibilities when ordering the test; in our small proof-of-
oncept study, 3 additional viral diagnoses were made using MNGS
Chikungunya virus in two cases and mumps virus in one). Fur-
hermore, MNGS has the potential to detect multiple pathogens
n a single sample. In our study, one patient (34) who had been
dmitted with Plasmodium falciparum infection but was noted to
ave prominent cervical lymphadenopathy and ongoing fever de-
pite treatment was found to have fragments of mumps virus fol-
owing MNGS. This was in keeping with ongoing symptoms of
ymphadenopathy and fever despite negative blood ﬁlms ( P. falci-
arum was not detected in this case, but at the time of sampling,
he blood ﬁlm was noted to be negative, having been positive at
n earlier time point). Full genome data generated by MNGS has
ther potential applications – for example, identiﬁcation of vir-
lence genes or resistance mutations including as minority vari-
nts and the identiﬁcation of clusters of infection using phyloge-
etic approaches. Infections of consequence can also be identiﬁed
nd relevant treatment and public health precautions carried out
n real time to aid the treatment of an affected patient. 29 In this
tudy, one returning traveller presented with a relapse of Ebola
irus disease associated with meningoencephalitis, 10 months after
er original presentation. In this case, the full open reading frame
f the virus was sequenced in real time both in plasma and cere-
rospinal ﬂuid in order to facilitate experimental treatment selec-
ion and was found to be identical in both sites on relapse. This
as the ﬁrst evidence of EBOV causing disease in the central ner-
ous system and the only available sequence obtained from cere-
rospinal ﬂuid – a site not previously considered to harbor the
irus. 
There are a number of limitations to this study. Firstly, our
ethod is designed to detect RNA viruses (the majority of viruses
ssociated with travel are RNA viruses) and employs a DNAse step
o reduce sequencing human genomic material. It is likely to detect
NA viruses with an RNA stage in the life cycle but with reduced
ensitivity. To increase the detection threshold for DNA viruses, a
ifferent approach such as target enrichment (allowing separation
f viral from host DNA) or removal of methylated DNA should be
onsidered. Secondly, we did not have the opportunity to test res-
iratory, CSF and urine samples in the majority of cases; however
thers have identiﬁed novel viral pathogens such as astroviruses
sing other body ﬂuids and tissues. 20,25,30 Thirdly, we have not
ormally measured sensitivity of MNGS for the detection of each
athogen identiﬁed in this study. We have previously evaluated the
hreshold for detection of the hepatitis C virus and MNGS can reli-
bly allow reconstruction of a full HCV genome above a threshold
f 10,0 0 0 IU/ml using MNGS and 10 0 0 IU/ml using target enrich-
ent approaches. 7 Finally, we did not design this study to include
nalysis of bacterial genomes. Further validation of this technique
nd the evaluation of detection sensitivity will be required as the
ethod is rolled out. Please cite this article as: H. Jerome, C. Taylor and V.B. Sreenu et al., Me
infections in febrile returning travellers, Journal of Infection, https://doThere are still barriers to overcome before MNGS is imple-
ented as a routine diagnostic assay. Firstly, MNGS is highly sub-
ect to cross-contamination and therefore stringent controls must
e in place to manage the pipeline (separation of preparation
ooms at each step of the sequencing pathway and strict bioin-
ormatic thresholds). Secondly cost considerations must be made.
t the time of writing, the cost of MNGS is approximately $100
SD/sample – this is not much higher than the cost of individual
ests requested in febrile patients from centralized specialist cen-
ers but will require consideration of batching and may only be
easible in major centers with a high throughput of patients. For-
al cost-effectiveness and validation studies are required. 
At the current time, the Illumina platform has the highest ac-
uracy, but this may not be essential when using the tool simply
o make a diagnosis. The portable MinIon platform has the poten-
ial as a bedside test but requires further development of library
reparation platforms that are also portable and a reduction in the
igh amount of starting material required at present. 31,32 Inaccu-
acy in sequence reads may not be of major importance if diagno-
is is the main goal, particularly with viruses where genomes are
xtremely diverse, differing from another by more than 30%. 
There is potential for MNGS to provide a single test to diag-
ose pathogens that may be viral, parasitic or bacterial on the basis
f speciﬁc syndromic manifestations, for example, returning trav-
llers with fever. However, wet lab techniques and bioinformatic
ethods will need to be adapted to issues associated with differ-
nt pathogens. Diagnosis of bacterial infections using MNGS may
e best carried out following culture or 16S PCR. The potential for
ontamination from bacteria on the skin surface must be consid-
red but is a lesser problem when identifying viral or parasitic
athogens. Malaria is an essential consideration in returning trav-
llers but may require adaptations of sample processing – for ex-
mple the use of whole blood would be likely to increase the sen-
itivity of detection of blood stage parasites but would carry the
ssociated need to carry out more sequencing due to dilution of
amples with host DNA. 33,34 It is even possible that a single sam-
le could yield information on host mutations rendering the pa-
ient more or less susceptible to certain agents (for example CCR5
eﬁciency is likely to provide protection against the HIV virus but
usceptibility to tick-borne encephalitis virus, West Nile virus and
nﬂuenza). 35,36 However, the development of such a test will re-
uire specialists from multiple specialities to co-ordinate and work
ogether to develop appropriate approaches to diagnosis. It is an
im well-worth pursuing. 
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